x
Filter:
Filters applied
- Reviews
- MSRemove MS filter
- proteomicsRemove proteomics filter
Publication Date
Please choose a date range between 2021 and 2022.
Author
- Bandeira, Nuno1
- Burnum-Johnson, Kristin E1
- Conrads, Thomas P1
- Deutsch, Eric W1
- Diamandis, Eleftherios P1
- Drake, Richard R1
- Entwisle, Samuel W1
- Herr, Amy E1
- Iyengar, Ravi1
- Kelleher, Neil L1
- Kelly, Ryan T1
- Kohlbacher, Oliver1
- Kulasingam, Vathany1
- Leutert, Mario1
- Lundberg, Emma1
- MacCoss, Michael J1
- Martens, Lennart1
- Naba, Alexandra1
- Nolan, Garry P1
- Pevzner, Pavel A1
- Ren, Annie H1
- Rodland, Karin D1
- Sechi, Salvatore1
- Slavov, Nikolai1
- Spraggins, Jeffrey M1
Reviews & Perspectives
5 Results
- PerspectiveOpen Access
New Views of Old Proteins: Clarifying the Enigmatic Proteome
Molecular & Cellular ProteomicsVol. 21Issue 7100254Published online: May 30, 2022- Kristin E. Burnum-Johnson
- Thomas P. Conrads
- Richard R. Drake
- Amy E. Herr
- Ravi Iyengar
- Ryan T. Kelly
- and others
Cited in Scopus: 0In Brief Capturing the biology of proteins will require improved technologies to readout their composition in space and time. Developing these improved technologies presents a major opportunity for biomedical research. How might we proceed in the decades ahead? - PerspectiveOpen Access
Data Management of Sensitive Human Proteomics Data: Current Practices, Recommendations, and Perspectives for the Future
Molecular & Cellular ProteomicsVol. 20100071Published online: March 9, 2021- Nuno Bandeira
- Eric W. Deutsch
- Oliver Kohlbacher
- Lennart Martens
- Juan Antonio Vizcaíno
Cited in Scopus: 0In Brief Availability of proteomics data in the public domain has become the norm, as it has been the case in genomics and transcriptomics for many years. Analogously to sequencing data, there are increasing ethical issues and legal requirements related to sensitive human clinical proteomics data. We review the current state of the art and make concrete recommendations to address these issues in the proteomics field, which are summarized in four different areas. - ReviewOpen Access
Decoding Post-Translational Modification Crosstalk With Proteomics
Molecular & Cellular ProteomicsVol. 20100129Published online: August 2, 2021- Mario Leutert
- Samuel W. Entwisle
- Judit Villén
Cited in Scopus: 32In Brief We provide an overview of current experimental and computational proteomic methods, as well as a perspective on emerging technologies to study PTM crosstalk. - ReviewOpen Access
Uncovering the Depths of the Human Proteome: Antibody-based Technologies for Ultrasensitive Multiplexed Protein Detection and Quantification
Molecular & Cellular ProteomicsVol. 20100155Published online: September 27, 2021- Annie H. Ren
- Eleftherios P. Diamandis
- Vathany Kulasingam
Cited in Scopus: 0In Brief Probing the human plasma proteome is attractive for biomarker and drug target discovery. Recent breakthroughs in multiplex proteomics technologies enable the simultaneous and sensitive quantification of thousands of proteins in biofluids. We provide a comprehensive guide to the methodologies, performance, advantages, and disadvantages of established and emerging technologies for the multiplexed ultrasensitive measurement of proteins. Gaining knowledge on these innovations is crucial for choosing the right multiplexed proteomics tool to critically complement traditional proteomics methods. - ReviewOpen Access
Chromatin Proteomics to Study Epigenetics — Challenges and Opportunities
Molecular & Cellular ProteomicsVol. 20100056Published online: February 5, 2021- Guido van Mierlo
- Michiel Vermeulen
Cited in Scopus: 0In Brief MS-based analysis of chromatin has emerged as a powerful tool to identify proteins associated with gene regulation. Total chromatin isolated from cells can be directly analyzed using MS, further fractionated into transcriptionally active and inactive chromatin, enriched for specific compartment or regions, and potentially used for single-locus isolation. This review highlights recent advances and discusses current challenges that should be addressed to further advance the field of chromatin proteomics.